Eli Lilly to target cancer drug developers for deals

(Reuters) - Eli Lilly and Co will target cancer drug developers for deals, Chief Executive Officer Dave Ricks said on a post-earnings conference call on Wednesday.

“Probably because of the number of opportunities, you will see us active in oncology - that’s where a lot of early stage biotech is,” Ricks said.

OCTOBER 23, 2019

https://www.reuters.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company